152 related articles for article (PubMed ID: 30040869)
1. Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma.
Tagawa M; Kurashima C; Takagi S; Maekawa N; Konnai S; Shimbo G; Matsumoto K; Inokuma H; Kawamoto K; Miyahara K
PLoS One; 2018; 13(7):e0201222. PubMed ID: 30040869
[TBL] [Abstract][Full Text] [Related]
2. Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Calvalido J; Wood GA; Mutsaers AJ; Wood D; Sears W; Woods JP
Vet Immunol Immunopathol; 2016 Dec; 182():106-114. PubMed ID: 27863540
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma.
Tagawa M; Maekawa N; Konnai S; Takagi S
PLoS One; 2016; 11(2):e0150030. PubMed ID: 26901565
[TBL] [Abstract][Full Text] [Related]
4. Checkpoint molecule expression by B and T cell lymphomas in dogs.
Hartley G; Elmslie R; Dow S; Guth A
Vet Comp Oncol; 2018 Sep; 16(3):352-360. PubMed ID: 29380929
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric expression of common antigens CD18/CD45 in blood from dogs with lymphoid malignancies: a semi-quantitative study.
Comazzi S; Gelain ME; Riondato F; Paltrinieri S
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):243-52. PubMed ID: 16698089
[TBL] [Abstract][Full Text] [Related]
6. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
7. Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors.
Kumar SR; Kim DY; Henry CJ; Bryan JN; Robinson KL; Eaton AM
Vet Comp Oncol; 2017 Dec; 15(4):1527-1536. PubMed ID: 28111882
[TBL] [Abstract][Full Text] [Related]
8. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
[TBL] [Abstract][Full Text] [Related]
9. Cytometric evaluation of peripheral blood lymphocytes in dogs with lymphoma during chemotherapy.
Winnicka A; Jagielski D; Hoffmann-Jagielska M; Lechowski R
J Vet Med A Physiol Pathol Clin Med; 2002 Aug; 49(6):303-6. PubMed ID: 12227473
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.
Solinas C; Garaud S; De Silva P; Boisson A; Van den Eynden G; de Wind A; Risso P; Rodrigues Vitória J; Richard F; Migliori E; Noël G; Duvillier H; Craciun L; Veys I; Awada A; Detours V; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
Front Immunol; 2017; 8():1412. PubMed ID: 29163490
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma.
Poggi A; Miniscalco B; Morello E; Comazzi S; Gelain ME; Aresu L; Riondato F
Vet Comp Oncol; 2015 Dec; 13(4):475-80. PubMed ID: 24341365
[TBL] [Abstract][Full Text] [Related]
12. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
Meichner K; Fogle JE; English L; Suter SE
J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high-grade B-cell lymphoma.
Poggi A; Miniscalco B; Morello E; Gattino F; Delaude A; Ferrero Poschetto L; Aresu L; Gelain ME; Martini V; Comazzi S; Riondato F
Vet Comp Oncol; 2017 Jun; 15(2):431-440. PubMed ID: 26792094
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic significance of programmed death protein 1 and programmed death ligand-1, and cytotoxic T lymphocyte-associated molecule-4 in hepatocellular carcinoma.
Chang H; Jung W; Kim A; Kim HK; Kim WB; Kim JH; Kim BH
APMIS; 2017 Aug; 125(8):690-698. PubMed ID: 28493410
[TBL] [Abstract][Full Text] [Related]
16. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Lesokhin AM; Ansell SM; Armand P; Scott EC; Halwani A; Gutierrez M; Millenson MM; Cohen AD; Schuster SJ; Lebovic D; Dhodapkar M; Avigan D; Chapuy B; Ligon AH; Freeman GJ; Rodig SJ; Cattry D; Zhu L; Grosso JF; Bradley Garelik MB; Shipp MA; Borrello I; Timmerman J
J Clin Oncol; 2016 Aug; 34(23):2698-704. PubMed ID: 27269947
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K
Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204
[TBL] [Abstract][Full Text] [Related]
18. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
19. Specific immunotypes of canine T cell lymphoma are associated with different outcomes.
Deravi N; Berke O; Woods JP; Bienzle D
Vet Immunol Immunopathol; 2017 Sep; 191():5-13. PubMed ID: 28895866
[TBL] [Abstract][Full Text] [Related]
20. Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
Keane C; Vari F; Hertzberg M; Cao KA; Green MR; Han E; Seymour JF; Hicks RJ; Gill D; Crooks P; Gould C; Jones K; Griffiths LR; Talaulikar D; Jain S; Tobin J; Gandhi MK
Lancet Haematol; 2015 Oct; 2(10):e445-55. PubMed ID: 26686046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
